Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based …

TT Horlocker, E Vandermeuelen, SL Kopp… - Obstetric Anesthesia …, 2019 - journals.lww.com
The American Society of Regional Anesthesia and Pain Medicine (ASRA) convened its
Fourth Consensus Conference on Regional Anesthesia and Anticoagulation in conjunction …

Interventional spine and pain procedures in patients on antiplatelet and anticoagulant medications: guidelines from the American Society of regional anesthesia and …

S Narouze, HT Benzon, D Provenzano… - Regional Anesthesia & …, 2018 - rapm.bmj.com
Abstract The American Society of Regional Anesthesia and Pain Medicine (ASRA) 2012
survey of meeting attendees showed that existing ASRA anticoagulation guidelines for …

The pathogenesis of sepsis

DJ Stearns-Kurosawa, MF Osuchowski… - Annual review of …, 2011 - annualreviews.org
Sepsis is a serious clinical condition that represents a patient's response to a severe
infection and has a very high mortality rate. Normal immune and physiologic responses …

Interventional spine and pain procedures in patients on antiplatelet and anticoagulant medications: guidelines from the American Society of Regional Anesthesia and …

S Narouze, HT Benzon, DA Provenzano… - Regional Anesthesia & …, 2015 - rapm.bmj.com
Interventional spine and pain procedures cover a far broader spectrum than those for
regional anesthesia, reflecting diverse targets and goals. When surveyed, interventional …

Comparative pharmacodynamics and pharmacokinetics of oral direct thrombin and factor Xa inhibitors in development

BI Eriksson, DJ Quinlan, JI Weitz - Clinical pharmacokinetics, 2009 - Springer
For the past five decades, there has been little progress in the development of oral
anticoagulants, with the choices being limited to the vitamin K antagonists (VKAs). The …

Importance of pharmacokinetic profile and variability as determinants of dose and response to dabigatran, rivaroxaban, and apixaban

IY Gong, RB Kim - Canadian Journal of Cardiology, 2013 - Elsevier
Warfarin has been the mainstay oral anticoagulant (OAC) medication prescribed for stroke
prevention in atrial fibrillation (AF) patients. However, warfarin therapy is challenging …

New oral anticoagulants: comparative pharmacology with vitamin K antagonists

F Scaglione - Clinical pharmacokinetics, 2013 - Springer
New oral anticoagulants (OACs) that directly inhibit Factor Xa (FXa) or thrombin have been
developed for the long-term prevention of thromboembolic disorders. These novel agents …

An indirect comparison of dabigatran, rivaroxaban and apixaban for atrial fibrillation

S Mantha, J Ansell - Thrombosis and haemostasis, 2012 - thieme-connect.com
New oral anticoagulant drugs are emerging as alternatives to warfarin for the prevention of
stroke in patients with non-valvular atrial fibrillation. Two agents are direct factor Xa …

Coagulation parameters in patients receiving dabigatran etexilate or rivaroxaban: two observational studies in patients undergoing total hip or total knee replacement

G Freyburger, G Macouillard, S Labrouche, F Sztark - Thrombosis research, 2011 - Elsevier
INTRODUCTION: Dabigatran and rivaroxaban have recently been added to the
armamentarium for thromboprophylaxis in orthopedic surgery. Although this is their first …

Laboratory measurement of the direct oral anticoagulants

BJ Dale, NC Chan… - British journal of …, 2016 - Wiley Online Library
Direct oral anticoagulants (DOAC s), including the direct thrombin inhibitor, dabigatran, and
the direct factor Xa (FX a) inhibitors, rivaroxaban, apixaban and edoxaban, are approved for …